Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- Cervical Spondylotic Myelopathy Surgical Trial: Complete Statistical AnalysisIndependent statistical analysis of Cervical Spondylotic Myelopathy Surgical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02076113).
- CESIndependent statistical analysis of The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CES1 Carriers in the PAPI Study: Complete Statistical AnalysisIndependent statistical analysis of CES1 Carriers in the PAPI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03188705).
- Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH): Complete Statistical AnalysisIndependent statistical analysis of Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00663858).
- Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab and Lenalidomide in Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Lenalidomide in Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01133665).
- Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA – NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC): primary endpoint results, effect estimate with confidence…
- CEUS For Intraoperative Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of CEUS For Intraoperative Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05530798).
- CGDNIndependent statistical analysis of N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265563).
- CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet: Complete Statistical AnalysisIndependent statistical analysis of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CHAARTEDIndependent statistical analysis of CHAARTED (NCT00309985), a randomized phase 3 trial of androgen-deprivation therapy with or without docetaxel in metastatic hormone-sensitive prostate cancer.
- CHALLENGEIndependent statistical analysis of Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer: primary endpoint results, effect estimate…
- Chamomile for Chronic Primary Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Chamomile for Chronic Primary Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01286324).
- CHAMPIndependent statistical analysis of Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02918292).
- CHAMPION 1Independent statistical analysis of A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CHAMPION 2Independent statistical analysis of A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CHAMPSIndependent statistical analysis of Connected Health Blood Pressure Monitoring In Stroke and TIA Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02450760).
- CHANGEIndependent statistical analysis of "CHANGE COVID-19 Severity": primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04941703).
- CHANGEIndependent statistical analysis of Increasing Activity Post-Kidney Transplant With SystemCHANGE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03191630).
- Change In Diaphragmatic Thickness Predicts Extubation Success: Complete Statistical AnalysisIndependent statistical analysis of Change In Diaphragmatic Thickness Predicts Extubation Success: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02656199).
- Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir: Complete Statistical AnalysisIndependent statistical analysis of Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Changes of Pain and Functional Parameters in Back Pain Patients Over Time: Complete Statistical AnalysisIndependent statistical analysis of Changes of Pain and Functional Parameters in Back Pain Patients Over Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ChangHER-SCIndependent statistical analysis of Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Changing in Skin Physiology After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces: Complete Statistical AnalysisIndependent statistical analysis of Changing in Skin Physiology After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Changing Lifestyles for Better Health: Complete Statistical AnalysisIndependent statistical analysis of Changing Lifestyles for Better Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00848757).
- Chantix for Treating Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Chantix for Treating Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567008).
- Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa: Complete Statistical AnalysisIndependent statistical analysis of Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Characteristics of Pts Initiating Spiriva Respimat in Asthma: Complete Statistical AnalysisIndependent statistical analysis of Characteristics of Pts Initiating Spiriva Respimat in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03692676).
- Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Characterization of Transient Alterations of Cutaneous Sensory Nerve Function by Cryolipolysis: Complete Statistical AnalysisIndependent statistical analysis of Characterization of Transient Alterations of Cutaneous Sensory Nerve Function by Cryolipolysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CHARGEIndependent statistical analysis of Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CHARMSIndependent statistical analysis of Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CHASE 2Independent statistical analysis of A Study in Asthmatic Children (6 to
- Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D: Complete Statistical AnalysisIndependent statistical analysis of Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CheckMate 066Independent statistical analysis of Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CheckMate 069Independent statistical analysis of Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval,…
- CheckMate 651Independent statistical analysis of Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma…
- CheckMate 8HWIndependent statistical analysis of A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC):…
- CheckMate 907Independent statistical analysis of Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CheckMate 914Independent statistical analysis of A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney: primary endpoint…
- CheckMate-017Independent statistical analysis of CheckMate-017, the randomized phase 3 trial of nivolumab versus docetaxel in previously treated advanced or metastatic squamous cell non-small cell lung cancer, including its overall-survival analysis and statistical…
- CheckMate-026Independent statistical analysis of CheckMate-026, a randomized phase 3 trial of nivolumab versus investigator's choice chemotherapy as first-line therapy for stage IV or recurrent PD-L1+ non-small cell lung cancer.
- CheckMate-141Independent statistical analysis of CheckMate-141, the randomized phase 3 trial of nivolumab versus investigator's choice therapy in recurrent or metastatic squamous cell carcinoma of the head and neck.
- CheckMate-816Independent statistical analysis of CheckMate-816, a randomized phase 3 trial of nivolumab plus platinum-doublet chemotherapy versus chemotherapy alone in early-stage non-small cell lung cancer.